Hall Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,547
Closed -$435K 109
2026
Q1
$435K Sell
7,547
-12,980
-63% -$1.04M 0.16% 73
2025
Q4
$1.96M Sell
20,527
-56
-0.3% -$5.49K 0.76% 40
2025
Q3
$2.01M Buy
20,583
+15,415
+298% +$1.6M 0.79% 41
2025
Q2
$555K Buy
+5,168
New +$523K 0.23% 60

Other funds holding BSX

Hall Capital Management's BSX Position: Q2 2026 in Review

Hall Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 7,547 shares — an estimated $435K sold.

Hall Capital Management first reported a position in BSX in Q2 2025 and held it in 4 quarters. The position peaked at $2.01M in Q3 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Hall Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Hall Capital Management sold 7,547 Boston Scientific shares in Q2 2026, an estimated $435K.
  • Hall Capital Management first reported a position in Boston Scientific in Q2 2025 and held it in 4 quarters.
  • Hall Capital Management's Boston Scientific position peaked at $2.01M in Q3 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Hall Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.